Mineralys Therapeutics, Inc. MLYS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $118.5M-10.2% | $132.01M-13.3% | $152.18M-12.9% | $174.71M-0.6% | $175.71M+4.2% | ||
| $53M+37.3% | $38.6M+20.9% | $31.92M+12.6% | $28.36M+10.0% | $25.78M+8.2% | ||
| $171.5M+0.5% | $170.6M-7.3% | $184.09M-9.3% | $203.07M+0.8% | $201.49M+4.7% | ||
| -$171.5M-0.5% | -$170.6M+7.3% | -$184.09M+9.3% | -$203.07M-0.8% | -$201.49M-4.7% | ||
| $19.71M+23.6% | $15.95M+25.4% | $12.72M+3.4% | $12.3M-5.2% | $12.97M-11.1% | ||
| $19.72M+23.6% | $15.95M+25.3% | $12.73M+3.5% | $12.29M-5.3% | $12.98M-11.1% | ||
| -$151.78M+1.9% | -$154.65M+9.8% | -$171.36M+10.2% | -$190.77M-1.2% | -$188.51M-6.0% | ||
| -$2.00+13.8% | -$2.32+21.4% | -$2.95+17.1% | -$3.56+4.6% | -$3.73-2.5% | ||
| -$171.45M-0.5% | -$170.55M+7.3% | -$184.03M+9.3% | -$203.01M-0.8% | -$201.44M-4.7% | ||
| -$171.5M-0.5% | -$170.6M+7.3% | -$184.09M+9.3% | -$203.07M-0.8% | -$201.49M-4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Mineralys Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Mineralys Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.